21 – 40 of 44
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence
(
- Contribution to journal › Article
- 2017
-
Mark
Familial associations of male breast cancer with other cancers
(
- Contribution to journal › Article
-
Mark
Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer : the Danish cohort of BIG 1-98
(
- Contribution to journal › Article
-
Mark
FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population
(
- Contribution to journal › Article
-
Mark
Androgen receptor expression and breast cancer mortality in a population-based prospective cohort
(
- Contribution to journal › Article
-
Mark
Aesthetic result after breast-conserving therapy is associated with quality of life several years after treatment. Swedish women evaluated with BCCT.core and BREAST-Q™
(
- Contribution to journal › Article
-
Mark
High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers
(
- Contribution to journal › Article
-
Mark
Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression : identification of a modifier of breast cancer risk at locus 11q22.3
(
- Contribution to journal › Article
- 2016
-
Mark
Amount of stroma is associated with mammographic density and stromal expression of oestrogen receptor in normal breast tissues
(
- Contribution to journal › Article
- 2012
-
Mark
Diagnostic values of GHSR DNA methylation pattern in breast cancer
(
- Contribution to journal › Article
- 2009
-
Mark
The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis : A prospective study
(
- Contribution to journal › Article
- 2008
-
Mark
Risk of familial breast cancer is not increased after pregnancy
(
- Contribution to journal › Article
-
Mark
Survival in breast cancer is familial
(
- Contribution to journal › Article
- 2007
-
Mark
Risk for contralateral breast cancers in a population covered by mammography : Effects of family history, age at diagnosis and histology
(
- Contribution to journal › Article
- 2006
-
Mark
Time dependent effects of tamoxifen treatment on cardiovascular morbidity
(
- Contribution to journal › Published meeting abstract
- 2005
-
Mark
Estrogen receptor (ER)-beta has favorable independent prognostic value for ER-alfa negative breast cancer patients receiving adjuvant tamoxifen
(
- Contribution to journal › Published meeting abstract
- 2003
-
Mark
Prolonged tamoxifen therapy; effects on contralateral breast cancer, endometrial cancer incidence and cardiovascular mortality
(
- Contribution to journal › Published meeting abstract
- 2001
-
Mark
Histological grade, its three components and flow cytometric S-phase as prognostic markers in premenopausal women with node negative breast cancer
(
- Contribution to journal › Published meeting abstract
- 2000
-
Mark
A randomised study of sector resection with and without radiotherapy for women with node-negative stage I and II breast cancer
(
- Contribution to journal › Published meeting abstract
- 1999
-
Mark
Vascular endothelial growth factor (VEGF) and urokinase plasminogen activator (uPA) are independent prognostic factors for distant recurrence in premenopausal node-negative breast cancer
(
- Contribution to journal › Published meeting abstract